Mg-Co / PCL composite scaffold and preparation method and application thereof

Through the use of Mg-Co/PCL composite scaffolding, the problems of low healing rate and high retear rate after rotator cuff repair surgery were solved. By promoting cell differentiation and regulating smooth muscle cells, the healing effect of the tendon-bone interface was successfully improved. , forming scar tissue with good strength, reducing inflammatory symptoms, and realizing the reconstruction of the complex tendon-bone interface.

CN118987361APending Publication Date: 2024-11-22GUANGDONG REGEN-MED SCI & TECH LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411279593.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The healing rate and retear rate after rotator cuff repair surgery are low, mainly due to the poor intensity of scar tissue formed by the tendon-bone interface, which cannot effectively reconstruct complex and distinctive tendon-bone interface tissue.

Method used

Using Mg-Co/PCL composite scaffold, magnesium and cobalt are combined with polycaprolactone to construct a biocompatible scaffold with porous structure, promoting cell adhesion, proliferation and differentiation, regulating the proliferation and fibrosis of smooth muscle cells, and improving tendons -The healing effect of the bone interface.

Benefits of technology

It improves the healing effect of the tendon-bone interface, forms scar tissue with a strength close to the normal interface, reduces inflammatory symptoms, enhances the plasticity of local tissues, and improves the long-term recovery effect after rotator cuff repair surgery.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention relates to the field of bone tissue engineering, and particularly discloses an Mg-Co / PCL composite material stent as well as a preparation method and application thereof. The total concentration of Mg and Co in the Mg-Co / PCL composite scaffold is 5-20 wt%, the Mg-Co / PCL composite scaffold is of a porous structure, the pore size is 297.83 + / -4.34 [mu] m-496.93 + / -4.39 [mu] m, the pore spacing is 200-300 [mu] m, and the Mg-Co / PCL composite scaffold has high mechanical strength and can accelerate crosslinking of smooth muscle cells of a tendon-bone interface and a bone interface, so that complex and well-layered tendon-bone interface tissue is reconstructed, and the tendon-bone interface tissue can be reconstructed. The purpose of repairing or regenerating damaged different tissue connecting parts is achieved, and the healing effect of the tendon-bone interface after the rotator cuff repairing operation is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of bone tissue engineering, specifically, to the field of biomaterial scaffolds, and more specifically, it relates to a Mg-Co / PCL composite material scaffold and a preparation method and application thereof. Background Art

[0002] Bone transplantation is a medical surgical technique used to repair or reconstruct bone defects caused by trauma, disease or other reasons. This technique is widely used in orthopedics, maxillofacial surgery, plastic surgery and neurosurgery. In bone transplantation surgery, doctors will choose the most suitable bone transplant material according to the specific situation of the patient. These bone transplant materials mainly include autologous bone, allogeneic bone and xenogeneic bone. Among them, autologous bone is the "gold standard" for clinical bone defect treatment. However, this method is not suitable for patients with a large bone demand and will cause trauma to the donor bone; the biggest problem of allogeneic bone and xenogeneic bone is immune rejection, and there are also ethical disputes. Therefore, more and more researchers have turned their attention to the rapidly developing bone tissue engineering. Bone tissue engineering is an emerging technical discipline that studies and develops biological substitutes for the repair, maintenance and promotion of the function and morphology of various bone tissues or organs in the human body after damage based on the correct understanding of the relationship between the structure and function of bone tissue in normal and pathological states of mammals. Its principle is to combine cells, biomaterials and bioactive factors to regenerate or repair bone defects through in vitro culture or construction to achieve the purpose of rebuilding important bone tissue functions of limbs. Among them, seed cells, biomaterial scaffolds and the interaction between them are the main aspects of bone tissue engineering research.

[0003] Biomaterial scaffolds are mainly made of biocompatible materials and can provide mechanical support and biomimetic environment for cell attachment and proliferation, protein production, and bone tissue regeneration. Among many biocompatible materials, polycaprolactone (PCL) has shown great application prospects in the field of bone tissue engineering and regenerative medicine due to its excellent biodegradability and modifiable properties, and has been approved by the FDA for use in clinical trials. What is more noteworthy is that compared with natural polymers, PCL has shown great design flexibility due to its lower melting point. With the help of three-dimensional printing, PCL scaffolds with personalized shapes and pore sizes can be customized. However, the hydrophobicity and low mechanical strength of PCL scaffolds limit its application range to a certain extent.

[0004] Rotator cuff tear is the most common type of rotator cuff injury, usually occurring at the hip end, which is a gradient composite tissue composed of tendons, unmineralized fibrocartilage, mineralized fibrocartilage, and bone. For patients with a large tear, good tendon activity, high muscle strength requirements, or no significant improvement after conservative treatment, rotator cuff repair surgery should be performed to achieve better treatment results. In rotator cuff repair surgery, the doctor will expose the damaged rotator cuff tissue through surgical incisions or arthroscopic techniques, and then use special sutures to reattach the rotator cuff tendon to the humerus after cleaning the specific area, restoring its normal anatomical results. However, the results of multiple systematic studies have pointed out that the average non-union rate after rotator cuff repair surgery is 26.6%, and the postoperative re-tear rate is as high as 79%. Most patients will experience symptoms such as pain, limited activity, and weakness after surgery, which seriously affects their daily lives, and some patients even need to undergo a second surgery. Some scholars believe that after rotator cuff repair surgery, the scar tissue formed at the tendon-bone interface is of poor strength, which is far from the normal tendon-bone interface. This is an important reason for repair failure and re-tear. Therefore, in recent years, how to better improve the healing effect of the tendon-bone interface after rotator cuff repair surgery has become a hot topic. Summary of the invention

[0005] In order to solve the above technical problems, the present application provides a Mg-Co / PCL composite material scaffold and applies it to the repair of the rotator cuff tendon-bone interface, so as to achieve the purpose of reconstructing complex and layered tendon-bone interface tissue and repairing or regenerating damaged connection sites of different tissues.

[0006] The present application provides a Mg-Co / PCL composite material bracket, which adopts the following technical solution: A Mg-Co / PCL composite material bracket, wherein the total concentration of Mg and Co in the Mg-Co / PCL composite material bracket is 5wt%-20wt%, and the Mg-Co / PCL composite material bracket is a porous structure with a pore size of 297.83±4.34μm-496.93±4.39μm and a pore spacing of 200μm-300μm.

[0007] By adopting the above technical solution, the present application uses magnesium (Mg) and cobalt (Co) as doped bioinorganic elements and polycaprolactone (PCL) to successfully construct a porous Mg-Co / PCL composite scaffold with suitable appearance and biological properties. The composite scaffold gives full play to the synergistic effect between the three materials of Mg, Co and PCL, so that the prepared composite scaffold not only has good biocompatibility and degradability, but also can provide cells with an indeterminate three-dimensional support structure, which is more conducive to cell adhesion, proliferation and differentiation. Mg mainly promotes the osteogenic differentiation of mesenchymal stem cells, while Co mainly induces collagen fiber regeneration by guiding the hypoxic environment (the fusion of the tendon-bone interface is usually in an hypoxic environment). Therefore, the Mg-Co / PCL composite material scaffold of the present application can not only effectively induce the proliferation of mesenchymal stem cells and promote the osteogenic differentiation of mesenchymal stem cells, but also regulate the proliferation of smooth muscle cells through the NF-kappa B signaling pathway, promote the synthesis and secretion of smooth muscle cell fibrosis matrix, and induce the phenotypic transformation of smooth muscle cells from a retractile type to a synthetic type, accelerate the cross-linking of smooth muscle cells and bone interfaces at the tendon-bone interface, and make the scar tissue formed at the tendon-bone interface stronger, which is almost the same as the normal tendon-bone interface. Different from simply promoting osteogenic differentiation, the Mg-Co / PCL composite material scaffold of the present application achieves the purpose of reconstructing complex and well-defined tendon-bone interface tissues, repairing or regenerating damaged different tissue connection sites, and improving the healing effect of the tendon-bone interface after rotator cuff repair surgery. In addition, the Mg-Co / PCL composite material scaffold of the present application can also promote the polarization of M2 macrophages, inhibit the polarization of M1 macrophages, reduce local inflammatory symptoms, and improve the plasticity of local tissues.

[0008] Preferably, the total concentration of Mg and Co in the Mg-Co / PCL composite material bracket is 5wt%-10wt%.

[0009] Preferably, the total concentration of Mg and Co in the Mg-Co / PCL composite material bracket is 10wt%.

[0010] Although the addition of Mg and Co can increase the mechanical strength of PCL materials, and can work together with PCL to promote the adhesion, proliferation and differentiation of mesenchymal stem cells, smooth muscle cells, etc. However, if the amount of Mg and Co added is too large, it will inhibit the adhesion, proliferation and differentiation of mesenchymal stem cells, smooth muscle cells, etc. Therefore, through the above-mentioned technical scheme, the present application further optimizes the total concentration of Mg and Co in the Mg-Co / PCL composite material scaffold, thereby further improving the effect of the composite material on promoting tendon-bone interface fusion. And experimental data have shown that when the total concentration of Mg and Co in the Mg-Co / PCL composite material scaffold is 10wt%, the mechanical strength of the composite material scaffold and the effect of promoting tendon-bone interface fusion are more balanced.

[0011] Optionally, the concentration ratio of Mg to Co in the Mg-Co / PCL composite material scaffold is (3-4):1.

[0012] Since Co is a rare element in the human body, it is not advisable to add too much. However, Co can regenerate collagen fibers and promote tendon-bone interface fusion. Therefore, the inventors of the present application have confirmed through a large number of experimental studies that when the concentration ratio of Mg and Co is (3-4):1, the Mg-Co / PCL composite material scaffold can have a good effect of promoting tendon-bone interface fusion when the Co addition amount is appropriate.

[0013] Preferably, the pore size of the Mg-Co / PCL composite material scaffold is 367.21±4.17 μm-412.78±4.21 μm.

[0014] Since the size of the pore size affects the mechanical strength and osteogenic differentiation of the Mg-Co / PCL composite material scaffold, as well as the effect on the tendon-bone interface fusion, if the pore size is too large, the mechanical strength is low, and the effective amount of Mg-Co / PCL per unit area is insufficient, which affects the proliferation of mesenchymal stem cells and smooth muscle cells, etc., and reduces the effect of tendon-bone interface fusion; if the pore size is too small, it will lead to insufficient adhesion of mesenchymal stem cells, smooth muscle cells, etc., which will still reduce the effect of tendon-bone interface fusion. In addition, osteogenic differentiation usually requires a larger pore size, which is more conducive to bone formation and capillary formation, while fibroblasts have extremely small requirements for pore size, usually between 5μm-15μm. Therefore, by adopting the above technical solution, the present application further optimizes the pore size of the Mg-Co / PCL composite material scaffold, so that the mechanical strength of the Mg-Co / PCL composite material scaffold of the present application and the effect of promoting tendon-bone interface fusion achieve the best balance.

[0015] In a second aspect, the present application provides a method for preparing a Mg-Co / PCL composite material scaffold, using the following technical solution: A method for preparing a Mg-Co / PCL composite material scaffold comprises the following steps: S1, dispersing nano-MgO, nano-CoCl2 and PCL in dichloromethane, and then precipitating and vacuum drying to obtain a Mg-Co / PCL nanocomposite with a total concentration of Mg and Co of 5wt%-20wt%; S2. The Mg-Co / PCL nanocomposite is melt-extruded to obtain a filament, and then the Mg-Co / PCL composite material scaffold is prepared by 3D printing technology.

[0016] By adopting the above technical solution, the present application melt-extrudes the Mg-Co / PCL nanocomposite into filaments, and then prints the filaments through a 3D printing device to form a Mg-Co / PCL composite material bracket. During the printing process, specific parameters are set according to the required pore size, pore spacing, pore shape, etc.

[0017] Preferably, the MgO nanoparticles are prepared by the following method: a. Ultrasonic dispersion of nano-MgO in water for 1.5 h to 2 h at a power of 800 W to 1200 W to obtain a MgO suspension; ultrasonic dispersion of polyvinyl alcohol in water for 20 min to 30 min at a power of 800 W to 1200 W to obtain a polyvinyl alcohol aqueous solution; wherein the weight ratio of nano-MgO to polyvinyl alcohol is 1:(0.25-0.35); b. Mix the MgO suspension and the polyvinyl alcohol aqueous solution, and disperse them ultrasonically at a power of 800W-1200W for 2h-2.4h, then centrifuge, wash, and dry to obtain polyvinyl alcohol-modified nano-MgO.

[0018] By adopting the above technical scheme, the present application further adopts polyvinyl alcohol to modify nano-MgO, which significantly reduces the possibility of agglomeration of nano-MgO, and because the hydroxyl groups on the polyvinyl alcohol can form hydrogen bonds with the oxygen atoms in PCL, the adhesion between nano-MgO and PCL is greatly enhanced, and the dispersion ability of nano-MgO in molten PCL is greatly improved, and the possibility of Mg in the Mg-Co / PCL composite material scaffold being dissolved in the human body is reduced, thereby enhancing the mechanical strength of the Mg-Co / PCL composite material scaffold and its role in improving the healing effect of the tendon-bone interface after rotator cuff repair surgery.

[0019] Preferably, in step S2, the temperature during melt extrusion is 90°C-135°C.

[0020] By adopting the above technical solution, the present application optimizes the temperature during melt extrusion, so that the wire can be uniformly and continuously produced, and the wire is not easy to break and is easy to shape, thus ensuring the quality of the wire. If the temperature is too low, the wire will be discontinuous and uneven; if the temperature is too high, the wire will be easy to break, difficult to shape, poor roundness, too flat, and other quality problems.

[0021] In a third aspect, the present application provides an application of a Mg-Co / PCL composite material scaffold in the repair of the rotator cuff tendon-bone interface.

[0022] In summary, this application has the following beneficial technical effects: 1. This application uses 3D printing technology to prepare a porous Mg-Co / PCL composite scaffold with suitable shape and biological properties, and the Mg-Co / PCL composite scaffold has high mechanical strength; 2. The Mg-Co / PCL composite scaffold of the present application has good immune inflammation regulation and antibacterial properties, can effectively promote the proliferation and osteogenic differentiation of mesenchymal stem cells, and at the same time regulate the proliferation, adhesion, and differentiation of smooth muscle cells through the NF-kappa B signaling pathway, accelerate the cross-linking of smooth muscle cells and bone interfaces at the tendon-bone interface, achieve the purpose of reconstructing complex and well-defined tendon-bone interface tissues, repairing or regenerating damaged connection sites of different tissues, and improving the healing effect of the tendon-bone interface after rotator cuff repair surgery; 3. The present application uses polyvinyl alcohol to modify nano-MgO, thereby greatly improving the dispersion ability of nano-MgO in molten PCL, reducing the possibility of Mg in the Mg-Co / PCL composite scaffold being dissolved in the human body, and increasing the micropore size of the Mg-Co / PCL composite scaffold, thereby enhancing the role of the Mg-Co / PCL composite scaffold in improving the healing effect of the tendon-bone interface after rotator cuff repair surgery. DETAILED DESCRIPTION

[0023] The present application is further described in detail below in conjunction with the performance test results of the preparation examples.

[0024] The shape and size of the Mg-Co / PCL composite material stent of the present application can be adjusted according to actual needs, and when placed in a wound, it needs to be cut according to the actual size of the wound. In the specific implementation of the present application, only one shape and size are provided as an example for illustration.

[0025] The polyvinyl alcohol used in the present application was purchased from Chengdu Cologne Chemicals Co., Ltd., model 1788.

[0026] <Preparation Example 1> A method for preparing a Mg-Co / PCL composite material scaffold comprises the following steps: S1. Dispersing nano-MgO and nano-CoCl2 in dichloromethane, then adding PCL and stirring to form a solution, precipitating the solution to obtain a nano-composite, and then vacuum drying the nano-composite to obtain a Mg-Co / PCL nano-composite with a total concentration of Mg and Co of 5 wt %; wherein the concentration ratio of Mg to Co is 4:1; S2. The Mg-Co / PCL nanocomposite is melt-extruded to obtain a wire with a diameter of 200 μm. During melt extrusion, the temperature of zone 1 is 90°C-130°C, and the temperature of zone 2 is 95°C-135°C. Then, the CAD software is used to design the Mg-Co / PCL composite material bracket model. The design shape is a square, the size is 5cm×5cm, the height is 1.5mm, the pore spacing is 200μm, the pore size is 297.83±4.34μm, and the angle is 60°. Then, the CAD model is input into the FDM printer, and the printer operating temperature is set to 110°C, the air pressure is 0.6MPa, and the speed is 6mm / s to obtain the Mg-Co / PCL composite material bracket.

[0027] <Preparation Example 2> A method for preparing a Mg-Co / PCL composite material scaffold comprises the following steps: S1. Dispersing nano-MgO and nano-CoCl2 in dichloromethane, then adding PCL and stirring to form a solution, precipitating the solution to obtain a nano-composite, and then vacuum drying the nano-composite to obtain a Mg-Co / PCL nano-composite with a total concentration of Mg and Co of 5 wt %; wherein the concentration ratio of Mg to Co is 3:1; S2. The Mg-Co / PCL nanocomposite is melt-extruded to obtain a wire with a diameter of 300 μm. During melt extrusion, the temperature of zone 1 is 90°C-130°C, and the temperature of zone 2 is 95°C-135°C. Then, the CAD software is used to design the Mg-Co / PCL composite material bracket model. The design shape is a square, the size is 5cm×5cm, the height is 1.5mm, the pore spacing is 300μm, the pore size is 297.83±4.34μm, and the angle is 60°. Then, the CAD model is input into the FDM printer, and the printer operating temperature is set to 110°C, the air pressure is 0.6MPa, and the speed is 6mm / s to obtain the Mg-Co / PCL composite material bracket.

[0028] <Preparation Example 3> A method for preparing a Mg-Co / PCL composite material bracket is different from Preparation Example 1 in that: in step S1, the total concentration of Mg and Co in the Mg-Co / PCL nanocomposite is 10wt%, and the rest is the same as Preparation Example 1.

[0029] <Preparation Example 4> A method for preparing a Mg-Co / PCL composite material bracket is different from Preparation Example 1 in that: in step S1, the total concentration of Mg and Co in the Mg-Co / PCL nanocomposite is 20wt%, and the rest is the same as Preparation Example 1.

[0030] <Preparation Example 5> A method for preparing a Mg-Co / PCL composite material bracket is different from Preparation Example 1 in that: in step S1, the total concentration of Mg and Co in the Mg-Co / PCL nanocomposite is 30wt%, and the rest is the same as Preparation Example 1.

[0031] <Preparation Example 6> A method for preparing a Mg-Co / PCL composite material scaffold, which is different from Preparation Example 1 in that: in step S2, the pore size is 367.21±4.17 μm, and the rest is the same as Preparation Example 1.

[0032] <Preparation Example 7> A method for preparing a Mg-Co / PCL composite material scaffold, which is different from Preparation Example 1 in that: in step S2, the pore size is 412.78±4.21 μm, and the rest is the same as Preparation Example 1.

[0033] <Preparation Example 8> A method for preparing a Mg-Co / PCL composite material scaffold, which is different from Preparation Example 1 in that: in step S2, the pore size is 496.93±4.39 μm, and the rest is the same as Preparation Example 1.

[0034] <Preparation Example 9> A method for preparing a Mg-Co / PCL composite material bracket is different from Preparation Example 1 in that: in step S1, nano-MgO is prepared by the following method: a. Ultrasonic dispersion of nano-MgO in deionized water for 1.5 h at a power of 800 W to obtain a MgO suspension; ultrasonic dispersion of polyvinyl alcohol in deionized water for 20 min at a power of 800 W to obtain a polyvinyl alcohol aqueous solution; wherein the weight ratio of nano-MgO to polyvinyl alcohol is 1:0.25; b. Mix the MgO suspension and the polyvinyl alcohol aqueous solution, and disperse them ultrasonically at a power of 800 W for 2 hours. Then, centrifuge, wash with a large amount of deionized water for 5 times, and vacuum dry to obtain polyvinyl alcohol-modified nano-MgO.

[0035] <Preparation Example 10> A method for preparing a Mg-Co / PCL composite material bracket is different from Preparation Example 1 in that: in step S1, nano-MgO is prepared by the following method: a. Ultrasonic dispersion of nano-MgO in deionized water for 2 h at a power of 1200 W to obtain a MgO suspension; ultrasonic dispersion of polyvinyl alcohol in deionized water for 30 min at a power of 1200 W to obtain a polyvinyl alcohol aqueous solution; wherein the weight ratio of nano-MgO to polyvinyl alcohol is 1:0.35; b. Mix the MgO suspension and the polyvinyl alcohol aqueous solution, and disperse them ultrasonically at a power of 1200 W for 2.4 hours. Then, centrifuge, wash with a large amount of deionized water for 5 times, and vacuum dry to obtain polyvinyl alcohol-modified nano-MgO.

[0036] <Preparation Example 11> A method for preparing a Mg-Co / PCL composite material bracket is different from Preparation Example 1 in that: in step S2, during melt extrusion, the temperature of zone 1 is 60°C-70°C, the temperature of zone 2 is 65°C-75°C, and the rest are the same.

[0037] <Preparation Example 12> A method for preparing a Mg-Co / PCL composite material bracket is different from Preparation Example 1 in that: in step S2, during melt extrusion, the temperature of zone 1 is 140°C-150°C, the temperature of zone 2 is 145°C-155°C, and the rest are the same.

[0038] <Performance Testing> 1. The mechanical strength of the Mg-Co / PCL composite material scaffolds prepared in Preparation Examples 1-12 was tested respectively. The mechanical strength mainly includes tensile strength and elastic modulus. The testing method is as follows: before testing, the Mg-Co / PCL composite material scaffold was cut into a size of 10 mm × 10 mm × 1.5 mm, and then tested using a universal mechanical testing machine with a tensile speed of 5 mm / min according to GB / T 16421-1996 and GB / T 9341-2008. The stress-strain curve was plotted, and the corresponding tensile strength and elastic modulus were obtained.

[0039] Table 1 Mechanical strength test results project Tensile strength(MPa) Elastic modulus (MPa) Preparation Example 1 17.0 529.18 Preparation Example 2 17.3 533.11 Preparation Example 3 17.3 534.27 Preparation Example 4 17.5 535.66 Preparation Example 5 17.6 536.11 Preparation Example 6 16.4 513.87 Preparation Example 7 16.0 442.67 Preparation Example 8 15.5 420.05 Preparation Example 9 17.3 532.26 Preparation Example 10 17.6 537.18 Preparation Example 11 10.01 227.49 Preparation Example 12 / / 2. Perform in vitro cell experiments on the Mg-Co / PCL composite scaffolds prepared in Preparation Examples 1-12. Before the in vitro cell experiments, prepare the extracts of each scaffold, sterilize the scaffold with ethylene oxide, and soak it in α-MEM culture medium at a ratio of 0.1g / ml according to ISO 10993-12 standard. After leaching in a cell culture incubator for 72 hours, collect, store and reserve. The in vitro cell experiments mainly include the effects on the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells, the effects on smooth muscle cells and the effects on macrophage polarization, and verify the effects on the molecular mechanism of smooth muscle cells. Among them, CCK8 experiment was used to detect the effect on the proliferation of bone marrow mesenchymal stem cells; ALP staining and alizarin red staining were used to detect the effects on the early and late osteogenic differentiation of bone marrow mesenchymal stem cells; CCK8 experiment was used to detect the effect on the proliferation ability of smooth muscle cells; ELISA experiment was used to detect the secretion levels of collagen such as COL-IV and HA in smooth muscle cells; Western blotting experiment was used to detect the effect on the differentiation ability of smooth muscle cells; ELISA experiment was used to detect the secretion levels of characteristic proinflammatory cytokines IL-1β, IL-6 and TNF-a of M1 macrophages (day 2).

[0040] Table 2 In vitro cell experiment results - bone marrow mesenchymal stem cells Table 3 In vitro cell experiment results - smooth muscle cells Table 4 In vitro cell experiment results - macrophages From Table 1-4 we can see that: The Mg-Co / PCL composite material scaffolds prepared in Preparation Examples 1-10 of the present application have high mechanical strength, can effectively induce the proliferation of mesenchymal stem cells, promote the osteogenic differentiation of mesenchymal stem cells, regulate the proliferation of smooth muscle cells, promote the synthesis and secretion of smooth muscle cell fibrosis matrix, induce the differentiation of smooth muscle cells, promote the cross-linking of smooth muscle cells and bone interfaces at the tendon-bone interface, and can also promote the polarization of M2 macrophages, inhibit the polarization of M1 macrophages, reduce local inflammatory symptoms, and improve the plasticity of local tissues.

[0041] Among them, the difference between Preparation Example 3-5 and Preparation Example 1 is the difference in the total content of Mg and Co. The experimental data show that as the total content of Mg and Co increases from 5wt% to 30wt%, the mechanical strength of the Mg-Co / PCL composite scaffold continues to increase, but the promoting effect on bone marrow mesenchymal stem cells, smooth muscle cells and macrophages begins to decline after reaching the maximum at 10wt%. Therefore, by further optimizing the total content of Mg and Co, the present application can achieve the best balance between the promoting effect and mechanical strength of the Mg-Co / PCL composite scaffold on bone marrow mesenchymal stem cells, smooth muscle cells and macrophages.

[0042] The difference between Preparation Examples 6-8 and Preparation Example 1 is that the pore size is different. The experimental data show that as the pore size increases, the promoting effect of the PCL / Mg composite scaffold on bone marrow mesenchymal stem cells, smooth muscle cells and macrophages first increases and then decreases, and the mechanical strength continues to decrease. Therefore, by further optimizing the pore size, the present application can achieve the best balance between the promoting effect and mechanical strength of the Mg-Co / PCL composite scaffold on bone marrow mesenchymal stem cells, smooth muscle cells and macrophages.

[0043] The difference between Preparation Example 9-10 and Preparation Example 1 is that polyvinyl alcohol is used to modify nano-MgO. Experimental data show that the use of nano-MgO modified with polyvinyl alcohol can further improve the mechanical strength of the Mg-Co / PCL composite material scaffold, while improving its promoting effect on bone marrow mesenchymal stem cells, smooth muscle cells and macrophages.

[0044] The difference between Preparation Examples 11-12 and Preparation Example 1 is that the melt extrusion temperature when preparing the filament in step S2 is different. The experimental results show that when the melt extrusion temperature is too low, the quality of the filament is poor, and the mechanical strength and promotion effect of the three types of cells of the prepared Mg-Co / PCL composite material scaffold are poor; when the melt extrusion temperature is too high, the filament breaks, resulting in the inability to prepare the Mg-Co / PCL composite material scaffold.

[0045] 3. In order to clarify the role of NF-kappa B signaling pathway in regulating smooth muscle cells in the Mg-Co / PCL composite scaffold prepared in Preparation Example 3, a pathway replenishment experiment was performed using SN50, a specific blocker of the NF-kappa B signaling pathway.

[0046] The experimental results showed that after adding the specific blocker SN50, the proliferation of smooth muscle cells on the Mg-Co / PCL composite scaffold was reduced by 40% after 48 hours of culture compared with the group without adding the blocker; the ECM secretion amount was tested by type IV collagen and HA, indicating that the addition of SN50 can also inhibit the secretion of smooth muscle collagen matrix, and the content of type IV collagen and the absolute value of HA were reduced by 35% and 70%, respectively; cell staining counting showed that after adding SN50, the number of cell adhesion in the Mg-Co / PCL culture environment was significantly reduced by 50%; transwell verified that the addition of SN50 can inhibit the migration of smooth muscle cells to a certain extent; specific proteins were characterized by western blotting, and by using GAPDH as the house-keeping gene, it was shown that the addition of SN50 can inhibit the expression of NF-kB, and the expression of α-SMA related to myosin was also significantly reduced.

[0047] It can be seen that the specific blocker SN50 can inhibit the smooth muscle cell proliferation, smooth muscle cell collagen matrix secretion and smooth muscle cell differentiation ability caused by Mg-Co / PCL composite scaffolds.

[0048] 4. The Mg-Co / PCL composite material scaffold prepared in Preparation Example 3 was subjected to an in vivo animal experiment. The surgical method was as follows: after the experimental rabbit was anesthetized successfully, it was placed on the animal surgical instrument table and fixed, and the lateral position was adopted. The right side was uniformly selected as the experimental group, and the contralateral side was selected as the normal group (no operation was performed). The experiment was divided into 2 groups. Group A did not implant any biomaterials after establishing the rotator cuff injury model, which was the control group; Group B established the rotator cuff injury model and implanted the Mg-Co / PCL composite material scaffold. The specific experimental operation method is as follows: select the right shoulder joint surgical area to shave the hair and prepare the skin, disinfect with iodine, lay a sterile sheet, and use a blade to cut the skin longitudinally at the rabbit shoulder joint. The incision is about 5 cm long, and the subcutaneous and subcutaneous fascia are cut in turn. The tissue around the supraspinatus muscle is bluntly separated and the supraspinatus muscle is freed. Use a sharp blade to cut the tendon at the attachment point of the supraspinatus tendon, establish a full-thickness rotator cuff injury tear model, and appropriately separate the muscle tissue around the supraspinatus tendon. The surface cartilage layer at the insertion point of the supraspinatus muscle on the greater tuberosity of the humerus was scraped with a blade to make the surface flat and the insertion point fresh, so as to facilitate better fit and repair of the supraspinatus tendon. For group A, a hand drill with a 0.8mm Kirschner wire was used to drill two bone tunnels from the attachment area of ​​the supraspinatus muscle to the front of the humeral head at an interval of 2mm at the insertion point of the greater tuberosity of the humerus. The tail end of the tendon was sutured with a 3-0 non-absorbable suture mattress. The two tail wires passed through the bone tunnel through the bone tunnel wire tool, and the medial supraspinatus tendon was pulled to the outer edge of the footprint area, completely covering the residual part of the footprint area, tightening the tail wire and tying a knot. For group B, a 5mm drill was used to drill a hole about 1mm deep near the outer edge of the greater tuberosity of the humerus to implant the Mg-Co / PCL composite scaffold. Two bone tunnels were established using the same method as group A, and the tail end of the tendon was sutured with a 3-0 non-absorbable suture mattress to repair the rotator cuff. Finally, the deltoid muscle and skin incisions on both sides were closed and sutured. The incision surface was disinfected again with iodine.

[0049] A total of 48 New Zealand rabbits were included in this experiment. Their mental, dietary, and activity status were evaluated before surgery to ensure that all animals were healthy. The recovery of rotator cuff repair surgery was evaluated by recording the linear motion activity time of each group of New Zealand rabbits after surgery.

[0050] Table 5 Overall evaluation of the repair of the rotator cuff tendon-bone interface by Mg-Co / PCL composite scaffold project 5 weeks(h) 7 weeks(h) 9 weeks(h) 14 weeks(h) Normal group 0.91 0.99 1.00 0.99 Group A 0.51 0.62 0.61 0.58 Group B 0.88 0.98 0.97 1.02 From Table 5 we can see that: The activity time of the experimental rabbits in Group A at 5, 7, 9 and 14 weeks after surgery was significantly lower than that in Group Normal, which indicates that the surgery was successful and the rotator cuff injury model of Group A was successful; while there was no significant difference in the activity time between Group B and the Normal group, which indicates that the recovery effect of Group B was very significant.

[0051] 5. A general evaluation was conducted on the experimental rabbits after surgery. The observation results were as follows: 4 weeks after surgery, one experimental rabbit in Group A had less activity in the right shoulder joint (operated side), and passive activity was not limited. The upper limbs of the animals in the other groups on the operated side were normal, without upper limb stiffness or limited joint activity. The incisions in the surgical areas of each group had no redness, swelling, or exudation, and healed at Grade A. After opening the original sutured skin, mild tissue adhesion was seen, and the transosseous suture line was in place. After opening the sutured skin, one experimental rabbit in Group A was found to have a postoperative shoulder joint infection, and the rotator cuff tissue was infiltrated with pus and necrotic tissue. No clear signs of infection were found in the other groups, and the tendon-bone was initially healed, with a small gap, scar tissue, and obvious inflammatory reaction.

[0052] At 12 weeks after surgery, the upper limbs of the animals in each group were normal, without stiffness of the upper limbs or limited joint movement. The incisions in the surgical areas of each group were free of redness, swelling, and exudation, and healed at grade A. A small amount of tissue adhesion was seen when the original incision was opened. One experimental rabbit in group A had a postoperative infection of the right shoulder joint. The rotator cuff tissue was infiltrated with pus and necrotic tissue. The cartilage surface of the humeral head was worm-eaten and uneven, and the suture was not completely absorbed. No rotator cuff infection was found in the other groups. In addition, the tendon-bone gap in group A showed obvious thickening of scar tissue, while the tendon-bone connection in group B was tighter than that at 4 weeks, with no gap.

[0053] 6. The postoperative experimental rabbits were evaluated histologically, and the results were as follows: HE staining results 4 weeks after surgery showed that the tendon-bone interface of group A and group B was composed of fibrous scars, among which the fibrous tissue of group B was denser; a large number of inflammatory cells infiltrated the tendon-bone interface, among which the inflammatory cells of group B were also less than those of group A; no obvious chondrocyte formation was observed in any group. HE staining results 12 weeks after surgery showed that the tendon-bone gaps in each group were tightly connected, and there were still a small number of inflammatory cells. Chondrocytes were seen locally, and loose and disordered Sharpey fibers were seen. Among them, chondrocytes grew into the tendon in group B, and chondrocytes and fibers were arranged neatly. Tide lines and dense Sharpey fibers were seen, and typical tendon-bone transitional structures were seen, which was better than group A. This shows that the Mg-Co / PCL composite material has good biocompatibility and can accelerate the repair of the rotator cuff tendon-bone interface by acting on inflammatory cells, smooth muscle cells or chondrocyte adhesion.

[0054] The results of safranin fast green staining 4 weeks after surgery showed that no obvious fibroblasts and chondrocytes were found at the tendon-bone interface in each group, the distribution of new blood vessels was less, the distribution of fibroblasts was denser than that of the control group, and irregularly arranged collagen fibers were formed between the tendon and bone. The results of safranin fast green staining 12 weeks after surgery showed that a small number of chondrocytes and a small number of fibroblasts were generated in group A, and a large number of chondrocytes and a small number of fibrochondrocytes were seen at the tendon-bone interface in group B, some of which differentiated into osteoblasts, and collagen fibers were formed between the tendon and bone, and the arrangement was still regular. New cartilage bands were seen at the tendon-bone interface, and some specimens showed structures similar to the normal rotator cuff insertion point.

[0055] In summary, the Mg-Co / PCL composite material scaffold of the present application has significant effects in anti-inflammation and accelerated healing in the process of repairing the rotator cuff tendon-bone interface, achieves the purpose of reconstructing complex and layered tendon-bone interface tissue, repairing or regenerating damaged connection sites of different tissues, and improves the healing effect of the tendon-bone interface after rotator cuff repair surgery.

[0056] The embodiments of this specific implementation method are all preferred embodiments of the present application, and are not intended to limit the protection scope of the present application. Therefore, all equivalent changes made based on the structure, shape, and principle of the present application should be included in the protection scope of the present application.

Claims

1. A Mg-Co / PCL composite material bracket, characterized in that: The total concentration of Mg and Co in the Mg-Co / PCL composite material scaffold is 5wt%-20wt%, and the Mg-Co / PCL composite material scaffold is a porous structure with a pore size of 297.83±4.34μm-496.93±4.39μm and a pore spacing of 200μm-300μm.

2. The Mg-Co / PCL composite material bracket according to claim 1, characterized in that: The total concentration of Mg and Co in the Mg-Co / PCL composite material bracket is 5wt%-10wt%.

3. The Mg-Co / PCL composite material bracket according to claim 2, characterized in that: The total concentration of Mg and Co in the Mg-Co / PCL composite material bracket is 10wt%.

4. A Mg-Co / PCL composite material bracket according to any one of claims 1 to 3, characterized in that: The concentration ratio of Mg to Co in the Mg-Co / PCL composite material scaffold is (3-4):

1.

5. The PCL / Mg composite material bracket according to claim 1, characterized in that: The pore size of the Mg-Co / PCL composite material scaffold is 367.21±4.17 μm-412.78±4.21 μm.

6. A method for preparing the Mg-Co / PCL composite material bracket according to claim 1, characterized in that: The following steps are involved: S1, dispersing nano-MgO, nano-CoCl2 and PCL in dichloromethane, and then precipitating and vacuum drying to obtain a Mg-Co / PCL nanocomposite with a total concentration of Mg and Co of 5wt%-20wt%; S2. The Mg-Co / PCL nanocomposite is melt-extruded to obtain a filament, and then the Mg-Co / PCL composite material scaffold is prepared by 3D printing technology.

7. The method for preparing a Mg-Co / PCL composite material bracket according to claim 6, characterized in that: The nano-MgO is prepared by the following method: At a power of 800W-1200W, nano-MgO is ultrasonically dispersed in water for 1.5h-2h to obtain a MgO suspension; at a power of 800W-1200W, polyvinyl alcohol is ultrasonically dispersed in water for 20min-30min to obtain a polyvinyl alcohol aqueous solution; wherein the weight ratio of nano-MgO to polyvinyl alcohol is 1:(0.25-0.35); The MgO suspension and the polyvinyl alcohol aqueous solution are mixed, and ultrasonically dispersed for 2h-2.4h at a power of 800W-1200W, and then centrifuged, washed, and dried to obtain polyvinyl alcohol-modified nano-MgO.

8. The method for preparing a Mg-Co / PCL composite material stent according to claim 6, characterized in that: In the step S2, the temperature during melt extrusion is 90°C-135°C.

9. Use of the Mg-Co / PCL composite material scaffold according to claim 1 in repairing the rotator cuff tendon-bone interface.